Qube Research & Technologies »

Singular Genomics Systems In shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Singular Genomics Systems In shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Singular Genomics Systems In

Tip: Access up to 7 years of quarterly data

All positions including Singular Genomics Systems In held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Singular Genomics Systems In by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $185 22 8.42

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Visa Com Cl A (V)
Microsoft Corporation (MSFT)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Merck & Co (MRK)
Accenture Plc Ireland Shs Class A (ACN)
Lam Research Corporation (LRCX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amgen (AMGN)
Adobe Systems Incorporated (ADBE)
NVIDIA Corporation (NVDA)

View all positions for Qube Research & Technologies

Top funds holding Singular Genomics Systems In

Deerfield Management Company
Arch Venture Corp
QVIDTVM Management
Perceptive Advisors
Vanguard Group
Casdin Capital
BlackRock
OrbiMed Advisors
HighTower Advisors
Geode Capital Management
Tikvah Management
Tower Research Capital
Barclays
Bank of America Corporation
Morgan Stanley

View all funds holding Singular Genomics Systems In